Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Bowles

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Melanoma Research|April 11, 2023
Feasibility of personalized circulating tumor DNA detection in stage II and III melanomaElise K Brunsgaard, Tawnya L Bowles, Elliot A Asare, et al.
Angewandte Chemie (International Ed. in English)|April 16, 2011
The cycloaddition reaction of I(h)-Sc₃N@C₈₀ with 2-amino-4,5-diisopropoxybenzoic acid and isoamyl nitrite to produce an open-cage metallofullereneGuan-Wu Wang, Tong-Xin Liu, Mingzhi Jiao, et al.
Annals of Surgical Oncology|April 7, 2010
Conditional survival estimates improve over 5 years for melanoma survivors with node-positive diseaseTawnya L Bowles, Yan Xing, Chung-Yuan Hu, et al.
Journal of the American Academy of Dermatology|March 3, 2018
Similar survival of patients with multiple versus single primary melanomas based on Utah Surveillance, Epidemiology, and End Results data (1973-2011)Douglas Grossman, James M Farnham, John Hyngstrom, et al.
Annals of Surgical Oncology|October 12, 2012
Sentinel lymph node biopsy for melanoma in pregnant womenRobert H I Andtbacka, Matthew R Donaldson, Tawnya L Bowles, et al.
Journal of the American Academy of Dermatology|December 31, 2013
Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalpBreanne E Terakedis, Christopher J Anker, Sancy A Leachman, et al.
Melanoma Research|June 21, 2019
Recurrence risk of early-stage melanoma of the external ear: an investigation of surgical approach and sentinel lymph node statusAmanda Truong, John R Hyngstrom, Robert H I Andtbacka, et al.
Oncotarget|July 9, 2016
A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanomaAbhijit Ray, Matthew A Williams, Stephanie M Meek, et al.
Melanoma Research|August 12, 2017
Risk factors for development of melanoma brain metastasis and disease progression: a single-center retrospective analysisLaura J Gardner, Morgan Ward, Robert H I Andtbacka, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Dramatic Responses to High-Dose Ipilimumab Plus Temozolomide After Progression on Standard- or Low-Dose Ipilimumab in Advanced MelanomaJulie Williamson, Muhammad Zaki Hidayatullah Fadlullah, Magdalena Kovacsovics-Bankowski, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Melanoma Research|April 11, 2023
Feasibility of personalized circulating tumor DNA detection in stage II and III melanomaElise K Brunsgaard, Tawnya L Bowles, Elliot A Asare, et al.
Angewandte Chemie (International Ed. in English)|April 16, 2011
The cycloaddition reaction of I(h)-Sc₃N@C₈₀ with 2-amino-4,5-diisopropoxybenzoic acid and isoamyl nitrite to produce an open-cage metallofullereneGuan-Wu Wang, Tong-Xin Liu, Mingzhi Jiao, et al.
Annals of Surgical Oncology|April 7, 2010
Conditional survival estimates improve over 5 years for melanoma survivors with node-positive diseaseTawnya L Bowles, Yan Xing, Chung-Yuan Hu, et al.
Journal of the American Academy of Dermatology|March 3, 2018
Similar survival of patients with multiple versus single primary melanomas based on Utah Surveillance, Epidemiology, and End Results data (1973-2011)Douglas Grossman, James M Farnham, John Hyngstrom, et al.
Annals of Surgical Oncology|October 12, 2012
Sentinel lymph node biopsy for melanoma in pregnant womenRobert H I Andtbacka, Matthew R Donaldson, Tawnya L Bowles, et al.
Journal of the American Academy of Dermatology|December 31, 2013
Patterns of failure and predictors of outcome in cutaneous malignant melanoma of the scalpBreanne E Terakedis, Christopher J Anker, Sancy A Leachman, et al.
Melanoma Research|June 21, 2019
Recurrence risk of early-stage melanoma of the external ear: an investigation of surgical approach and sentinel lymph node statusAmanda Truong, John R Hyngstrom, Robert H I Andtbacka, et al.
Oncotarget|July 9, 2016
A phase I study of intratumoral ipilimumab and interleukin-2 in patients with advanced melanomaAbhijit Ray, Matthew A Williams, Stephanie M Meek, et al.
Melanoma Research|August 12, 2017
Risk factors for development of melanoma brain metastasis and disease progression: a single-center retrospective analysisLaura J Gardner, Morgan Ward, Robert H I Andtbacka, et al.
Current Oncology (Toronto, Ont.)|March 26, 2025
Dramatic Responses to High-Dose Ipilimumab Plus Temozolomide After Progression on Standard- or Low-Dose Ipilimumab in Advanced MelanomaJulie Williamson, Muhammad Zaki Hidayatullah Fadlullah, Magdalena Kovacsovics-Bankowski, et al.
Pageof 12